Product Information
OXAZEPAM 15 MG CAPSULE is a generic product labeled by Leading Pharma, LLC, priced at $0.9674 per EA under NDC 69315091201. Its NADAC has been published 52 times since Aug 27, 2025.
FDA first approved this application on Mar 3, 2025. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
15 mg/1
Manufacturer
Leading Pharma, LLCNDC
69315091201
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
OXAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA218261FDA Approved
3/3/2025
TE Code
AB
On Market Since
7/9/2025
Pharmacological Classes
Price Statistics
The NADAC for OXAZEPAM 15 MG CAPSULE has been published 52 times since Aug 27, 2025, and over the history we have for it it has declined 10.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9674 per EA |
|---|---|
| All-time high | $1.0980 (Nov 12, 2025) |
| All-time low | $0.9674 (Aug 19, 2026) |
| 52-week high | $1.0980 |
| 52-week low | $0.9674 |
| Median price | $1.0683 |
| Average price | $1.0620 |
| Largest weekly change | -5.4% (Aug 19, 2026) |
| Weeks tracked | 52 |
| Tracking since | Aug 27, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the OXAZEPAM market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of OXAZEPAM 15 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for OXAZEPAM 15 MG CAPSULE, manufactured by Leading Pharma, LLC, is $0.9674 per EA (NDC 69315091201), effective Aug 19, 2026.
How has the price of OXAZEPAM 15 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for OXAZEPAM 15 MG CAPSULE has declined 10.1%. It has been tracked across 52 weekly CMS publications since Aug 27, 2025.
What are the highest and lowest recorded NADAC prices for OXAZEPAM 15 MG CAPSULE?
Since Aug 27, 2025, the NADAC for OXAZEPAM 15 MG CAPSULE has ranged from a low of $0.9674 (Aug 19, 2026) to a high of $1.0980 (Nov 12, 2025), with a median of $1.0683 per EA.
Are there cheaper alternatives to OXAZEPAM 15 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of OXAZEPAM 15 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures OXAZEPAM 15 MG CAPSULE?
OXAZEPAM 15 MG CAPSULE (NDC 69315091201) is labeled by Leading Pharma, LLC, and CMS classifies it as a generic product.